Microfluidic platforms for monitoring cardiomyocyte electromechanical activity
Abstract Cardiovascular diseases account for ~40% of global deaths annually. This situation has revealed the urgent need for the investigation and development of corresponding drugs for pathogenesis due to the complexity of research methods and detection techniques. An in vitro cardiomyocyte model i...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-01-01
|
| Series: | Microsystems & Nanoengineering |
| Online Access: | https://doi.org/10.1038/s41378-024-00751-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841544492421742592 |
|---|---|
| author | Wei Wang Weiguang Su Junlei Han Wei Song Xinyu Li Chonghai Xu Yu Sun Li Wang |
| author_facet | Wei Wang Weiguang Su Junlei Han Wei Song Xinyu Li Chonghai Xu Yu Sun Li Wang |
| author_sort | Wei Wang |
| collection | DOAJ |
| description | Abstract Cardiovascular diseases account for ~40% of global deaths annually. This situation has revealed the urgent need for the investigation and development of corresponding drugs for pathogenesis due to the complexity of research methods and detection techniques. An in vitro cardiomyocyte model is commonly used for cardiac drug screening and disease modeling since it can respond to microphysiological environmental variations through mechanoelectric feedback. Microfluidic platforms are capable of accurate fluid control and integration with analysis and detection techniques. Therefore, various microfluidic platforms (i.e., heart-on-a-chip) have been applied for the reconstruction of the physiological environment and detection of signals from cardiomyocytes. They have demonstrated advantages in mimicking the cardiovascular structure and function in vitro and in monitoring electromechanical signals. This review presents a summary of the methods and technologies used to monitor the contractility and electrophysiological signals of cardiomyocytes within microfluidic platforms. Then, applications in common cardiac drug screening and cardiovascular disease modeling are presented, followed by design strategies for enhancing physiology studies. Finally, we discuss prospects in the tissue engineering and sensing techniques of microfluidic platforms. |
| format | Article |
| id | doaj-art-1d8c7e736a3a4202b6442e950be71d04 |
| institution | Kabale University |
| issn | 2055-7434 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Nature Publishing Group |
| record_format | Article |
| series | Microsystems & Nanoengineering |
| spelling | doaj-art-1d8c7e736a3a4202b6442e950be71d042025-01-12T12:27:53ZengNature Publishing GroupMicrosystems & Nanoengineering2055-74342025-01-0111112210.1038/s41378-024-00751-zMicrofluidic platforms for monitoring cardiomyocyte electromechanical activityWei Wang0Weiguang Su1Junlei Han2Wei Song3Xinyu Li4Chonghai Xu5Yu Sun6Li Wang7School of Mechanical Engineering, Qilu University of Technology (Shandong Academy of Sciences)School of Mechanical Engineering, Qilu University of Technology (Shandong Academy of Sciences)School of Mechanical Engineering, Qilu University of Technology (Shandong Academy of Sciences)Department of Minimally Invasive Comprehensive Treatment of Cancer, Shandong Provincial Hospital Affiliated to Shandong First Medical UniversityDepartment of Minimally Invasive Comprehensive Treatment of Cancer, Shandong Provincial Hospital Affiliated to Shandong First Medical UniversitySchool of Mechanical Engineering, Qilu University of Technology (Shandong Academy of Sciences)Department of Mechanical and Industrial Engineering, University of TorontoSchool of Mechanical Engineering, Qilu University of Technology (Shandong Academy of Sciences)Abstract Cardiovascular diseases account for ~40% of global deaths annually. This situation has revealed the urgent need for the investigation and development of corresponding drugs for pathogenesis due to the complexity of research methods and detection techniques. An in vitro cardiomyocyte model is commonly used for cardiac drug screening and disease modeling since it can respond to microphysiological environmental variations through mechanoelectric feedback. Microfluidic platforms are capable of accurate fluid control and integration with analysis and detection techniques. Therefore, various microfluidic platforms (i.e., heart-on-a-chip) have been applied for the reconstruction of the physiological environment and detection of signals from cardiomyocytes. They have demonstrated advantages in mimicking the cardiovascular structure and function in vitro and in monitoring electromechanical signals. This review presents a summary of the methods and technologies used to monitor the contractility and electrophysiological signals of cardiomyocytes within microfluidic platforms. Then, applications in common cardiac drug screening and cardiovascular disease modeling are presented, followed by design strategies for enhancing physiology studies. Finally, we discuss prospects in the tissue engineering and sensing techniques of microfluidic platforms.https://doi.org/10.1038/s41378-024-00751-z |
| spellingShingle | Wei Wang Weiguang Su Junlei Han Wei Song Xinyu Li Chonghai Xu Yu Sun Li Wang Microfluidic platforms for monitoring cardiomyocyte electromechanical activity Microsystems & Nanoengineering |
| title | Microfluidic platforms for monitoring cardiomyocyte electromechanical activity |
| title_full | Microfluidic platforms for monitoring cardiomyocyte electromechanical activity |
| title_fullStr | Microfluidic platforms for monitoring cardiomyocyte electromechanical activity |
| title_full_unstemmed | Microfluidic platforms for monitoring cardiomyocyte electromechanical activity |
| title_short | Microfluidic platforms for monitoring cardiomyocyte electromechanical activity |
| title_sort | microfluidic platforms for monitoring cardiomyocyte electromechanical activity |
| url | https://doi.org/10.1038/s41378-024-00751-z |
| work_keys_str_mv | AT weiwang microfluidicplatformsformonitoringcardiomyocyteelectromechanicalactivity AT weiguangsu microfluidicplatformsformonitoringcardiomyocyteelectromechanicalactivity AT junleihan microfluidicplatformsformonitoringcardiomyocyteelectromechanicalactivity AT weisong microfluidicplatformsformonitoringcardiomyocyteelectromechanicalactivity AT xinyuli microfluidicplatformsformonitoringcardiomyocyteelectromechanicalactivity AT chonghaixu microfluidicplatformsformonitoringcardiomyocyteelectromechanicalactivity AT yusun microfluidicplatformsformonitoringcardiomyocyteelectromechanicalactivity AT liwang microfluidicplatformsformonitoringcardiomyocyteelectromechanicalactivity |